Skip to main content

Correction to: ZMYND10, an epigenetically regulated tumor suppressor, exerts tumor-suppressive functions via miR145-5p/NEDD9 axis in breast cancer

The Original Article was published on 04 December 2019

Correction to: Clinical Epigenetics (2019) 11:184 https://doi.org/10.1186/s13148-019-0785-z

Following the publication of this article, the authors noted that images of SK-BR-3 group in Fig. 9B were misplaced by mistake. The corrected Fig. 9B and corresponding bar graph is now shown in this correction. The authors confirm that the conclusions of this paper are not affected, and sincerely apologize for this error and any inconvenience that may have caused.

Fig. 9
figure 9

Transfected with miR145-5p inhibitor in MDA-MB231 and SK-BR-3 cell partially reversed ZMYND10’s effect on migration and invasion. a Effect of miR145-5p inhibitor transfection on the migration of MDA-MB231 and SK-BR-3 cells. b Effect of miR145-5p inhibitor transfection on the invasion of MDA-MB231 and SK-BR-3 cells. **p < 0.01; ***p < 0.001

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tingxiu Xiang.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Wang, Y., Dan, L., Li, Q. et al. Correction to: ZMYND10, an epigenetically regulated tumor suppressor, exerts tumor-suppressive functions via miR145-5p/NEDD9 axis in breast cancer. Clin Epigenet 14, 36 (2022). https://doi.org/10.1186/s13148-022-01256-0

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13148-022-01256-0